Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 86922879 |
Registration Number | 5242378 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Austin Padgett |
Attorney Docket Number | 244169.4 |
Law Office Assigned | N20 |
Employee Name | FRIEDMAN, LESLEE ANN |
2016-02-29 | Application Filed |
2016-09-27 | Published for Opposition |
2017-01-03 | Date of First Use |
2017-06-05 | Location: PUBLICATION AND ISSUE SECTION |
2017-07-11 | Status: Live/Registered |
2017-07-11 | Trademark Registered |
2018-07-08 | Transaction Date |
Owner: | ![]() |
Entity Statement | limited company (ltd.) |
Address | 2nd Floor, Block 10, Unit 1 Blanchardstown Corporate Park Dublin 15 IE |
Legal Entity Type | |
Legal Entity State | IE |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations and medications for use in the treatment of hypotension in the setting of anesthesia; pharmaceutical preparations and medications for treating pain management, respiratory diseases and disorders, allergic disorders, gastrointestinal disorders, sleep disorders, dermatological conditions, pulmonary diseases, obstetrics and gynecology; pharmaceutical products, namely, pharmaceutical agents and preparations for the treatment of autoimmune diseases, bacterial infections, chronic anemia, hypotension, disorders of the musculo-skeletal system, for maintaining blood pressure, for the reversal of the effects of anesthesia, for the reversal of the effects of non-depolarizing neuromuscular blocking agents; chemical preparations for medical and veterinary purposes for injection or oral administration, namely, a drug delivery system in the form of coatings, tablets that provide continuous and controlled release of active ingredients in a wide variety of therapeutic agents to human patients; drug delivery agents in the form of encapsulated pharmaceutical preparations for the prolonged and controlled release of active ingredients, for the treatment of a wide variety of diseases and disorders; injectable medication used to reverse anesthesia; medication used to maintain blood pressure |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2016-03-03 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2016-03-03 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2016-06-13 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2016-06-13 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2016-06-13 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2016-06-13 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2016-07-27 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-07-27 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-07-28 | 9 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2016-08-15 | 10 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2016-08-15 | 11 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2016-08-15 | 12 GNFN O:Outgoing Correspondence |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2016-08-16 | 13 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2016-08-16 | 14 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2016-08-16 | 15 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2016-08-18 | 16 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2016-09-07 | 17 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2016-09-27 | 18 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-09-27 | 19 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2016-11-22 | 20 NOAM E:E-Mail |
TEAS STATEMENT OF USE RECEIVED | 2017-05-09 | 21 EISU I:Incoming Correspondence |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2017-06-02 | 22 AITU A:Allowance for Publication |
USE AMENDMENT FILED | 2017-05-09 | 23 IUAF S: |
STATEMENT OF USE PROCESSING COMPLETE | 2017-06-04 | 24 SUPC I:Incoming Correspondence |
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2017-06-05 | 25 CNPR P: |
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2017-06-06 | 26 SUNA E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2017-07-11 | 27 R.PR A:Allowance for Publication |
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-07-11 | 28 REM1 E:E-Mail |
TEAS SECTION 8 & 15 RECEIVED | 2022-07-13 | 29 E815 I:Incoming Correspondence |
CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2023-01-31 | 30 APRE A:Allowance for Publication |
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | 2023-02-02 | 31 C15A O:Outgoing Correspondence |
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | 2023-02-02 | 32 NA85 E:E-Mail |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2023-06-15 | 33 COAR I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2023-06-15 | 34 CHAN I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2023-06-15 | 35 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2023-06-15 | 36 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2023-06-15 | 37 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2023-06-15 | 38 TCCA I:Incoming Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.